Have your own idea? Try our Stock Screener
UPDATED Nov 22, 2024
Discover U.S. Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the NYSE and NASDAQ and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on ‘Advanced Filters’.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SIGA | US$6.48 | 9.1% | 14.9% | US$447.7m | n/a | PE5.4x | S7.5% | 9.3% | ||
OGN | US$15.28 | 1.7% | 34.5% | US$3.8b | US$22.38 | PE3x | E-7.1% | 7.3% | ||
PFE | US$25.65 | 3.4% | -15.9% | US$142.4b | US$32.55 | PE34x | E16.8% | 6.5% | ||
BMY | US$58.87 | 4.7% | 18.3% | US$118.1b | US$59.37 | PS2.5x | E48.6% | 4.1% | ||
PRGO | US$28.07 | 4.7% | -9.1% | US$3.7b | US$35.80 | PB0.8x | E63.8% | 3.9% | ||
ABBV | US$176.95 | 7.2% | 27.6% | US$303.5b | US$204.74 | PE61.5x | E28.1% | 3.7% | ||
VTRS | US$13.37 | 4.2% | 41.8% | US$15.8b | US$13.08 | PS1.1x | E53.5% | 3.6% | ||
GILD | US$90.19 | 2.0% | 19.6% | US$111.9b | US$96.89 | PE892.1x | E40.7% | 3.4% | ||
JNJ | US$155.17 | 0.8% | 1.8% | US$374.4b | US$174.89 | PE25.3x | E10.6% | 3.2% | ||
RPRX | US$26.43 | 2.8% | -2.3% | US$15.6b | US$41.53 | PE10.3x | E6.3% | 3.2% | ||
MRK | US$99.18 | 3.0% | -2.6% | US$252.6b | US$130.85 | PE20.7x | E15.6% | 3.1% | ||
AMGN | US$294.53 | 3.9% | 11.0% | US$155.8b | US$334.06 | PE37.4x | E19.1% | 3.1% | ||
QGEN | US$42.78 | 3.7% | 1.5% | US$9.4b | US$50.59 | PE102.3x | E34.4% | 3.0% | ||
ILMN | US$140.14 | 3.8% | 42.5% | US$21.7b | US$164.60 | PS5.1x | E70.4% | 2.2% | ||
PAHC | US$23.74 | -2.9% | 125.2% | US$962.4m | US$18.40 | PE55.2x | E60.0% | 2.0% | ||
ZTS | US$176.96 | 1.0% | -1.8% | US$79.7b | US$214.78 | PE32.9x | E9.9% | 1.0% | ||
A | US$133.84 | 5.3% | 5.7% | US$37.9b | US$150.11 | PE27.2x | E4.1% | 0.7% | ||
LLY | US$748.01 | 0.2% | 24.4% | US$675.3b | US$992.18 | PE80.5x | E29.2% | 0.7% | ||
MLAB | US$109.09 | 6.5% | 19.1% | US$547.8m | US$133.33 | PS2.6x | E134.3% | 0.6% | ||
TECH | US$71.28 | 5.5% | 11.4% | US$11.3b | US$85.25 | PE75.2x | E21.2% | 0.4% | ||
DHR | US$235.84 | 2.3% | 6.5% | US$169.8b | US$290.13 | PE43.3x | E14.0% | 0.4% | ||
BRKR | US$57.07 | 11.2% | -13.2% | US$8.5b | US$74.74 | PE28.4x | E32.3% | 0.4% | ||
TMO | US$513.26 | 0.04% | 4.6% | US$197.4b | US$653.94 | PE32x | E11.5% | 0.3% | ||
STVN | US$19.65 | 3.4% | -29.6% | US$5.4b | US$26.25 | PE44.9x | E20.3% | 0.3% |